BAC BV collaborates with Life Technologies to provide new HPLC affinity columns

22-Jun-2011 - BAC BV has announced a strategic collaboration with Life Technologies to bring the wide range of BAC’s CaptureSelect® affinity ligand specificities to Life Technologies’ POROS® chromatography media and pre-packed HPLC columns. The collaboration will create a range of ready-to-use HPLC columns ...

DNA Sequencing Data Reveals New Hybrid E. coli Strain is Cause of German Outbreak

06-Jun-2011 - Life Technologies Corporation announced that preliminary data from DNA sequencing performed in cooperation with the University Hospital Muenster, Germany, on the Ion Personal Genome Machine (PGM™) strongly suggests that the bacterium at the root of the deadly outbreak in Germany is a new hybrid ...

CEVEC Signs Global License Agreement for Human CAP-T Technology with Life Technologies

19-Aug-2010 - CEVEC Pharmaceuticals announced the signing of a co-exclusive worldwide licensing agreement with Life Technologies Corporation. Under the terms of the agreement, Life Technologies and CEVEC will co-operate to offer optimized expression kits based on CEVEC’s proprietary CAP-T cells to the global ...

GENEART AG and Applied Biosystems Deutschland GmbH intend to conclude a domination agreement

11-Jun-2010 - GENEART AG and its majority shareholder, Applied Biosystems Deutschland GmbH, intend to conclude a domination agreement pursuant to Section 291 et seq. German Stock Corporation Act (Aktiengesetz) with GENEART AG as the dominated entity and Applied Biosystems Deutschland GmbH as the dominating ...

Management Board and Supervisory Board of GENEART Recommends Acceptance of Voluntary Public Offer

19-Apr-2010 - The Management Board and the Supervisory Board of GENEART AG have announced their joint statement with respect to the voluntary public offer by Applied Biosystems Deutschland GmbH to the shareholders of GENEART AG. This joint statement is in reference to the offer document published by the ...

GENEART AG will become part of the US-Based Biotechnology Company Life Technologies Corp.

Life Technologies acquires 58 % of GENEART shares via it´s German subsidiary Applied Biosystems Deutschland GmbH

09-Apr-2010 - The founders of GENEART AG Prof. Dr. Ralf Wagner, Prof. Dr. Hans Wolf, Dr. Marcus Graf, and individual members of the management as well as the venture capital companies EquiNet EarlyStage Capital and S-REFIT AG, have signed contracts with Applied Biosystems Deutschland GmbH for selling their ...

Invitrogen Announces Opening of Hepatocyte Supply Facility in Warrington, UK

08-Dec-2009 - Invitrogen, part of Life Technologies Corporation, announced the opening of a new facility in Warrington, UK, which will supply freshly isolated human hepatocytes to researchers in Europe. Human hepatocytes isolated from liver tissue are used for many biopharmaceutical applications, by ...

Life Technologies to Sell Mass Spectrometry Business to Danaher for $450 Million in Cash

07-Sep-2009 - Life Technologies Corporation announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies’ joint ...

SciGene Signs Reagent Supply Agreement with Life Technologies

23-Mar-2009 - SciGene announced that it has entered into an agreement whereby Invitrogen, a division of Life Technologies, will supply SciGene reagents used in its BioPrime® Total Genomic Labeling System. SciGene will incorporate the reagents into a kit for use on the ArrayPrep™ Target Preparation System, a ...

QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

26-Jan-2009 - Corbett, QIAGEN, ltf Labortechnik GmbH & Co. KG, and Applied Biosystems, LLC, part of Life Technologies Corporation announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene_TM Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument ...